3. Non-Small Cell Lung Carcinoma without Activating the Mutation of Epidermal Growth Factor Receptor (EGFR) or Anaplastic Lymphoma Kinase (ALK). This evidence concerns the gene EGFR and non-small cell lung carcinoma.